Table 2.
Descriptive analysis of the primary and secondary outcomes in the two study groups bolus and infusion
| Bolus group (n = 892) | Infusion group (n = 873) | P | |
|---|---|---|---|
| Overall postpartum adverse outcome | 138 (15.5 %) | 142 (16.3 %) | 0.70 |
| PPH | 131 (14.7 %) | 133 (15.2 %) | 0.80 |
| Severe PPH | 29 (3.2 %) | 34 (3.9 %) | 0.55 |
| Manual removal of the placenta | 28 (3.1 %) | 42 (4.8 %) | 0.09 |
| Curettage | 40 (4.5 %) | 45 (5.2 %) | 0.58 |
| Placenta retention >30 min | 57 (6.4 %) | 61 (7.0 %) | 0.68 |
| Uterine atony | 30 (3.4 %) | 32 (3.7 %) | 0.83 |
| Red blood cell transfusion | 7 (0.8 %) | 13 (1.5 %) | 0.24 |
| Transfer to the ICU | 10 (1.1 %) | 8 (0.9 %) | 0.85 |
| Estimated blood loss (ml) | 439.96 (±332.91) | 463.17 (±323.83) | 0.00019 |
| Decrease in haemoglobin (g/l) | 17.24 (±15.11) | 18.12 (±14.73) | 0.12 |
| Duration of the third stage of labour (min) | 11.88 (±12.32) | 12.34 (±12.46) | 0.17 |
Frequencies (percentages) and P values from a χ 2 test are shown for categorical outcomes. The mean (±standard deviation) and P values from a Mann–Whitney test are shown for continuous outcomes